BridgeBio Oncology Therapeutics, Inc.

BBOT · NasdaqGM

$2.82+4.65%(+0.13)

Yahoo Finance · delay unknown · USD · just in

Price history

Oct 28, 2025 · 11.25 USDOct 28, 2026 · 2.82 USD

Yahoo Finance · delay unknown · USD · 5 h old

Information, not investment advice.

Morgan Stanley lowered its price target for BridgeBio Oncology while keeping an overweight rating on the stock.· summarised by Stockedin

BBOT

Finnhub · delay unknown · 7 days old

Headline and publisher summary only; full articles stay with the source.